Images, video and audio from this Web site are provided without login for the purpose of editorial use only.
You must contact media@ford.com to obtain approval for advertising, marketing or other commercial users.
Ford Media Center
The first retail production Shelby® GT350R Mustang, VIN 001, fetched $1,000,000 for charity at the Barrett-Jackson Scottsdale auction at WestWorld today. Ford Motor Company auctioned the car at No Reserve, with proceeds benefiting JDRF, the leading global organization funding type 1 diabetes research.
After an electrifying bidding war, purchase of the first retail production Shelby GT350R was made by an anonymous bidder who is now the proud owner of this coveted vehicle. They have also made an important contribution to JDRF’s goal to progressively remove the impact of type 1 diabetes from people’s lives.
In 1965, Ford and Carroll Shelby developed a road-racing version of the popular Ford Mustang – the Shelby GT350 Competition model. Lighter, more powerful and with a highly developed suspension, it is one of the most iconic racing Mustangs ever produced.
Arriving later this year, the new Shelby GT350R has been designed and engineered in the same spirit, delivering never-before-seen track capability from a Mustang – thanks to innovations in aerodynamics, chassis engineering and light-weighting technologies.
“We knew the auction of this coveted car would capture the attention of serious enthusiasts,” said Steve Ling, Ford North American Car Marketing manager. “This was one of the most exhilarating auctions to witness, and the winning bidder is taking home a piece of history.”
Shelby GT350R features the first-ever production V8 from Ford with a flat-plane crankshaft – the most powerful naturally aspirated engine Ford has ever produced – plus a specially tuned suspension. It features revised spring rates and antiroll bars, bushings and jounce bumpers, as well as control calibration for the MagneRide dampers, a lower ride height, unique track-tuned alignment settings and cross-axis ball joints in front. Complete vehicle specs and images of the car can be found here.
"JDRF is honored to share in Ford’s 50-year celebration of the new Shelby GT350R at Barrett-Jackson Scottsdale,” said Derek Rapp, JDRF president and CEO. “As the leading charitable funder of type 1 diabetes research, JDRF is extremely proud of our long-time partnership with Ford, and we are tremendously thankful for Ford’s continued support of JDRF. JDRF benefits greatly from this partnership, which is an essential element of our pursuit of our shared vision of a world without type 1.”
Together, Ford Motor Company and Barrett-Jackson have raised more than $8 million at various auctions benefiting local and national charities.
Ford Motor Company (NYSE: F) is a global company based in Dearborn, Michigan, committed to helping build a better world, where every person is free to move and pursue their dreams. The company’s Ford+ plan for growth and value creation combines existing strengths, new capabilities and always-on relationships with customers to enrich experiences for customers and deepen their loyalty. Ford develops and delivers innovative, must-have Ford trucks, sport utility vehicles, commercial vans and cars and Lincoln luxury vehicles, along with connected services. The company does that through three customer-centered business segments: Ford Blue, engineering iconic gas-powered and hybrid vehicles; Ford Model e, inventing breakthrough electric vehicles along with embedded software that defines exceptional digital experiences for all customers; and Ford Pro, helping commercial customers transform and expand their businesses with vehicles and services tailored to their needs. Additionally, Ford provides financial services through Ford Motor Credit Company. Ford employs about 174,000 people worldwide. More information about the company and its products and services is available at corporate.ford.com.
JDRF is the leading global organization focused on type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF collaborates with a wide spectrum of partners and is the only organization with the scientific resources, regulatory influence and a working plan to bring life-changing therapies from the lab to the community. As the largest charitable supporter of T1D research, JDRF is currently sponsoring $568 million in charitable research in 17 countries. For more information, please visit http://www.jdrf.org/.